Form 8-K - Current report:
SEC Accession No. 0001193125-13-337722
Filing Date
2013-08-16
Accepted
2013-08-16 11:15:24
Documents
3
Period of Report
2013-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d585770d8k.htm 8-K 14893
2 EX-99.1 d585770dex991.htm EX-99.1 6393
3 GRAPHIC g585770g20h89.jpg GRAPHIC 4383
  Complete submission text file 0001193125-13-337722.txt   28887
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
Actavis, Inc. (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13305 | Film No.: 131044237
SIC: 2834 Pharmaceutical Preparations